Status:

WITHDRAWN

The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

Lead Sponsor:

Meir Medical Center

Conditions:

Pregnancy

Preeclampsia

Eligibility:

FEMALE

18-50 years

Brief Summary

The involvement of eukaryotic translation initiation factor 4E (eIF4E) in human placental implantation and in the pathological pregnancies: preeclampsia and IUGR.

Detailed Description

4 groups

Eligibility Criteria

Inclusion

  • post TOP or DELIVERY

Exclusion

  • \-

Key Trial Info

Start Date :

September 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2012

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01179542

Start Date

September 1 2010

End Date

October 1 2012

Last Update

September 13 2017

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR | DecenTrialz